>>> Santander -2.9% heading lower - see this article in the WSJ

Investors Say Santander's Brazil Buyback Comes as Unit Set for Turnaround
Investors Say Offer Will Act as Red Flag for Future IPOs

MADRID—Two of the largest shareholders in the Brazilian unit of Banco Santander SA SAN.MC -2.09% say the Spanish lender's offer to buy back the 25% stake it doesn't own puts pressure on them to take a loss just as they believe the unit's declining share value is set to rebound.

Santander's surprise offer, these minority shareholders say, is a red flag for potential investors in its future initial public offerings, including one planned for its U.K. subsidiary. The offer goes against the bank's stated strategy of taking, and keeping, its units public, they say.

Executives at Tweedy, Browne Co. LLC and Brandes Investment Partners L.P. say they haven't decided whether to sell their shares in Banco Santander Brasil SA, SANB11.BR -0.60% which were priced at 23.50 Brazilian reais ($10.60) when Santander took the unit public in 2009. The U.S. investment firms are the third- and fourth-largest holders of shares in the unit, according to the most recent data from Morningstar, MORN -2.04% Inc. Together they own 104 million shares, 2.74% of the total.

While Santander executives say the buyback deal will slightly boost the bank's overall earnings, the investors face a dilemma: Sell to Santander now at the bank's offered price of 15.31 reais per share, or risk holding a very small proportion of the unit's publicly traded shares if other shareholders accept the buyback offer.

The fewer the shares traded in a market, the less liquid-or harder to sell-they usually are.

"We are left with a decision of whether to play Russian roulette," said William H. Browne, a managing director at Tweedy, Browne, which is based in Stamford, Conn.

"Any investor interested in making an investment in a future flotation of a Santander subsidiary should look very carefully at the parent's record with regard to their treatment of minority shareholders," he added. "I think there is a reasonable chance if it's in their financial interest, they'll run right over your financial interests despite what they might say to the contrary."

Santander's Chief Financial Officer José Antonio Álvarez said in an interview that the offer is "a significant premium that the minorities can take or not take, while at the same time being profitable for Santander shareholders."


Santander is offering to swap shares in the Brazil unit for a portion of shares in the parent company. That trade would price the Brazil unit shares 20% above the share's closing price on the day before the offer was announced. The bank has said it expects to maintain the offer until October.

Mr. Álvarez met in London this week with Santander shareholders, including those with a stake in the Brazil unit.

When the offer was announced on April 28, Santander Chief Executive Javier Marín said the bank's strategy to have its subsidiaries publicly traded "doesn't change at all."

But in Brazil, he said "the market doesn't believe in our franchise and we do, and that's why we're carrying out this transaction."

Shares in the Brazilian unit have declined around 40% between the day it went public and the day before the tender offer. During the same period shares of Brazilian rivals Banco Bradesco SA BBDC4.BR -0.91% and Itaú Unibanco Holdings SA have gained.

Tito Labarta, a bank analyst at Deutsche Bank AG DBK.XE -1.31% , said in an April 29 research note that Santander's buyback offer "more than offsets another relatively weak quarter in Brazil." He added: "We think it makes sense to tender the shares, as liquidity after the offering is likely to be very limited."

Some investors might pause knowing that Santander, a bank known for shrewd deals, is interested in buying back the shares, said Rui Croca, a bank analyst with rating firm DBRS Inc. "I think the shareholders might be thinking, 'If Santander is buying, they might be buying it for a reason. Why should we let Santander get the upside?'" Mr. Croca said.

Executives at Tweedy Browne and Brandes said they believe the Santander unit will become more profitable.

"We recognize the near term outlook is challenging, but we think long-term and we believe that Santander Brasil has attractive longer-term prospects," said Michael Hutchens, director of investments at Brandes, which is based in San Diego. "Unfortunately, tendering shareholders will only receive a portion of the future benefits of these attractive prospects as holders of Santander Group shares."

Thomas H. Shrager, a managing director at Tweedy, Browne, said Santander Brasil sharpened its loan-underwriting standards several years ago. As the older loans start to mature, those newer loans, with fewer defaults, will start to boost the bank's profits, he said.

"So in about one year, the bank will be worth more than it is now, but Santander is offering to buy us out at the absolute bottom," Mr. Shrager said.

Tweedy, Browne executives also say they are concerned that if they remain investors in Santander Brasil, their shares will trade on a section of the São Paulo stock exchange that has less strict corporate governance standards.

The unit's shares are now listed on Level 2 of the exchange, a section that sets higher governance standards than the traditional market does. Level 2 places limits on board members' tenures, for instance. If a small portion of shareholders accept Santander's buyback offer, the percentage of Santander Brasil's publicly traded shares would fall below 25% of the total and the bank would be required to move to the traditional market.

"We're not going to change our standards of governance," Santander's Mr. Álvarez said.

The top shareholder after Santander, Qatar Holding LLC, owns 5.17% of Santander Brasil. Representatives for Qatar Holding, an arm of the Gulf emirate's main sovereign-wealth fund, didn't respond to requests for comment.

Shareholders shouldn't be completely caught off guard by Santander's move, some analysts say.

"Some investors have raised the point that there may be a reputational cost for the Santander Group of buying out subsidiaries below previous IPO prices," Iñigo Vega, an analyst with Nau Securities Ltd. in London wrote in a May 2 research note.

This risk is "nothing new," he wrote. Investors should "already be discounting such behavior."

Santander has done this before, he recalled.

In December 2012 it offered to buy the 10.26% stake in Banco Español de Crédito SA that it didn't own for "well below IPO pricing level," Mr. Vega wrote. Still, he added, Santander had no trouble in January this year drumming up strong demand for the IPO of its U.S. auto-lending unit.

WSJ : Euro Zone Stuck in First Gear

Euro Zone Stuck in First Gear
Pressure on ECB Will Grow and Government Bond Yields Could Fall Further

These weren't the growth numbers the euro zone was looking for. Gross domestic product in the economies that share the single currency grew just 0.2% in aggregate in the first quarter, half the pace forecast and a real disappointment that contrasts with upbeat sentiment data.

The numbers challenge the European Central Bank's belief in a gradual economic pickup and will increase fears about persistent low inflation. That will encourage markets to bet even more heavily on ECB action—even if quantitative easing remains the bank's last-resort option.

Overall, there were more negative surprises than positive in Thursday's data. Of the 13 euro-zone countries that reported quarter-on-quarter data, six contracted, one stagnated and six expanded. Germany grew 0.8%, a strong result thanks exclusively to domestic demand, and Spain showed signs of benefiting from its economic overhaul efforts, gaining 0.4%.


But disappointments were many. France managed to underperform expectations for slight growth and stagnated, while Italy's economy unexpectedly went into reverse, shrinking 0.1%. The big shock came from the Netherlands, where GDP fell 1.4% on the quarter—although a big chunk may be the result of a warm winter that led natural-gas exports to fall by more than a quarter year-on-year. Still, the decline in Dutch output was enough to knock 0.1 percentage point off euro-zone growth as a whole.

True, the headline numbers are somewhat at odds with survey and other data. Markit's purchasing managers index, the European Commission's Economic Sentiment Indicator and the Banca d'Italia's EuroCOIN index, which has historically tracked euro-zone GDP well, have all been upbeat recently. While the warm winter led to weak industrial production due to lower energy demand, euro-zone manufacturing output has been buoyant, rising at a 3.7% annualized rate in the first quarter, JP Morgan notes. Retail sales have been rising.

Nevertheless, the failure of the euro zone to accelerate will mean more calls for action from the ECB. Had growth improved in general, that would have helped the ECB's case: it could be argued that France and Italy really need domestic efforts to carry out economic reforms rather than just further loose monetary policy. But slow growth across the euro zone is a concern, as it means the output gap will close only slowly, weighing on inflation. The ECB Thursday published its latest survey of professional forecasters, which saw projections for inflation lowered across the board, with 2016 inflation seen at just 1.5%.

The figures support a number of trades that are already in train: government bond yields could yet fall further on expectation of an ECB response, and euro-denominated corporate bonds should fare well. The euro has fallen sharply in the past week, and could come under further pressure.

ECB President Mario Draghi has said that policy makers were "comfortable with acting" at the bank's June meeting. Faced with a slow-moving euro-zone recovery, the ECB may now need to shift its response up a gear.

>>> US Gapping down

Gapping down

In reaction to disappointing earnings/guidance: VOXX -21.5% (also downgraded to Neutral from Buy at B. Riley & Co), RGSE -14.7%, XONE -13.4%, NTES -7.8%, WX -6.3%, PT -6.1%, SEAS -3.5%, KSS -3.4%, WMT -3.2%, DANG -2.9%, JACK -2.8%, A -1.5%, USU -1.1%, (USEC Inc. reports large Q1 net loss -- Chapter 11 process continues; co anticipates emerging this summer).

M&A news: BSX -0.4% (announces definitive agreement to acquire interventional division of Bayer AG for $415 mln in cash), AAPL -0.2% (acquisition of Beats has been moved back by 7 days, according to reports).

Other news: LIQD -30.4% (thinly traded, still checking on catalyst), SRNE -17.9% (prices 4,765,000 shares of common stock at a public offering price of $5.25 per share), NBG -13.3% (still checking), INCY -8.8% ( following release of ASCO abstracts; Presents data from two trials involving ruxolitinib), AMRN -7.9% (announces private exchange transactions regarding outstanding Senior Exchangeable Notes), SIR -5.2% (announces proposed public offering of 8 mln common shares ), DCIX -5.1% (still checking), SIR -4.9% (prices 9 mln shares of common stock at $29.00 per share), DK -1.9% (prices 9.2 mln shares of its common stock offered by Delek Hungary y (the Selling Stockholder) at $30.00 per share), ALU -1.5% (still checking), DDD -0.9% and SSYS -0.5% (following XONE results), PCYC -0.6% ( highlights new data for IMBRUVICA (ibrutinib) in B-cell malignancies).

Analyst comments: MTGE -1.6% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities), VOD -1.3% ( downgraded to Neutral from Buy at Goldman ), ITC -1.1% (ITC Holdings downgraded to Neutral from Overweight at JPMorgan), BMY -0.2% (downgraded to Mkt Perform from Outperform at BMO Capital Mkts ), O -0.1% ( downgraded to Neutral from Buy at Ladenburg Thalmann)

>>> US Gapping up

Gapping up

In reaction to strong earnings/guidance: TNK +9.9% (ticking higher), VIPS +8%, CSCO +7.2%, TSEM +6.7%, SANW +6.6%, (light volume), OPWR +4.1%, (light volume), AGYS +3.4%, (light volume), CA +3.1%, AEG +1.4% (light volume), GOL +0.5% .

M&A news: GTIV +52.2% (Gentiva Health Svcs receives proposal to be acquired by Kindred Healthcare for a combination of $7.00 per share in cash and $7.00 of Kindred common stock ), DTV +0.5% (AT&T has hired Lazard to advise on DTV buyout, according to reports).

Tech/CSCO peers trading higher: SYMC +2.8% (ValueAct disclosed stake; also following CSCO results), JNPR +1.6%, FFIV +1.5%, CIEN +1.1%, VMW +0.8%, FTNT +0.8%,

Select financial related names showing strength: HSBC +1.9%, BCS +1.4%, IBN +0.8%.

A few miners are trading higher: BBL +1.3%, RIO +1.1%, BHP +0.3%.

Biotech/drug names higher: CLVS +8.2% (confirmed clinical data to be presented at 2014 ASCO Annual Meeting; also mentioned by Adam Feuerstein -- highlights lung cancer related names ), MNTA +4.7% (on TEVA Copaxone news), ISIS +4.5% (ISIS Pharm earns a $3.0 mln milestone payment from GlaxoSmithKline (GSK) related to the initiation of a natural history study), XNPT +3.7% (Xenoport and Reckitt Benckiser Pharmaceuticals Enter Into Global Licensing Agreement for Arbaclofen Placarbil), CLDX +1.7% (announces Varlilumab (CDX-1127) Phase 1 clinical data to be presented at ASCO Annual Meeting 2014), MYL +1.6% (comments on ruling against Teva in their suit against the FDA, which denied Teva's motion to block FDA from approving generic versions of Copaxone and dismissed the case for lack of jurisdiction).

Select China internet names getting boost following VIPS results: WUBA +1%, YY +0.7%, QIHU +0.7%, SINA +0.5%, VNET +0.3%

Other news: NWBO +17.8% (announces first data from ongoing DCVAX-Direct trial; evidence indicates substantial tumor necrosis and initial tumor regression), DRL +10.9% (calls on the Puerto Rico government to honor its obligations), AMED +3.6% (following GTIV news), DQ +2.8% (modestly rebounding), WILN +2.2% (concludes strategic review, formulates growth plan; to increase dividend 25%), DNDN +1.9% (announces presentation of PROVENGE and DN24-02 immuno-oncology data at the 2014 ASCO annual meeting), RATE +1.6% (following CEO insider buy), JDSU +1.5% (following A results), DQ +1.4% (prices 2 mln ADSs at $29.00 per share ), WWE +1.3% (following late move higher on tv contract speculation), UL +0.9% (still checking), HFC +0.8% (announces increase in regular dividend by 6.6% to $0.32 per share and declares additional $0.50 special dividend), BDBD +0.8% (positive MadMoney mention), MUR +0.3% ( announces additional $125 mln share repurchase program; also may sell Malaysia oil and gas assets for $ 2 bln, according to reports ), EXPD +0.2% (ValueAct discloses updated portfolio positions in 13F filing).

Analyst comments: NMBL +7.8% (upgraded to Buy from Neutral at Goldman; tgt lowered to $34 from $46), PLUG +6% (upgraded to Outperform from Mkt Perform at Cowen; tgt lowered to $6 from $7.50), MILL +2.3% (assumed with a Buy (from hold) at Brean Capital), KMI +1.9% (added to Conviction Buy list at Goldman), TWTR +1.1% ( upgraded to Neutral from Underweight at Atlantic Equities), SRC +1% (upgraded to Buy from Neutral at Ladenburg Thalmann)

>>> Tubos Reunidos looks for acquisitions and JVs as part of its growth strategy

Tubos Reunidos looks for acquisitions and JVs as part of its growth strategy, source says


Tubos Reunidos [MCE: TRG], the Spanish, listed seamless steel tubes maker, is looking for acquisitions and joint ventures as part of its 2014-2017 business plan, a company source said.

Any deals or JVs would have to help the company execute its new business plan, the source said. The main points of the plan are specializing in premium products, developing new products, increasing its regional presence and growing its services division, Almesa.

The company will study the acquisition of companies that complete its range of products, strengthen Almesa or help it enter target markets such as the US, the source said. In the US, Tubos Reunidos would be particularly interested in buying a company that specialises in finishing tubular products or a company that can offer value-added services to its clients, the source said.

Tubos Reunidos is also interesting in increasing its presence in Latin America, North Africa and the Middle East, the source said. The company could study buying a target or entering a JV with a local player, the source added.

The company has an in-house team to analyse markets and suggestions from advisors, the source said, adding that it would like to hear from advisors with more proposals.

Tubos Reunidos could also study commercial agreements with other tubular products makers, the source said.

Meanwhile, the company is not planning a rights issue, the source said. In case a big deal arises, it could finance it in the markets (with bonds or a bullet loan) or with a rights issue, the source added.

Although the company is not looking for a merger, possible opportunities must be analysed, the source said.

Tubos Reunidos hit EUR 42m in EBITDA and EUR 350m in revenues last year.

A spokesperson for the company declined to comment.

by Iñaki Miguel in Madrid


Source Proprietary Intelligence

>>> Gazprom OAO Reportedly Gazprom and China National Petroleum Corporation (CNP


Gazprom OAO Reportedly Gazprom and China National Petroleum Corporation (CNPC) will sign a 30-year natural gas delivery contract when Russia President Putin visits China next week - press
- The 30-year delivery contract between Gazprom and CNPC for 38 billion cubic meters of natural gas per year, with the potential to expand the annual capacity to 61 billion cubic meters 
- Construction of the pipeline between China and Russia will likely begin by the end of the year, and with operations beginning in 2018.